View Older Stories View More Recent Stories

Nov 16, 2022 04:43PM Vyant Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
Nov 16, 2022 04:43PM Vyant Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
Nov 15, 2022 08:00AM Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business Highlights
Nov 15, 2022 08:00AM Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business Highlights
Nov 10, 2022 05:13PM Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at the 2022 CDKL5 Forum Hosted by the Loulou Foundation
Nov 10, 2022 05:13PM Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at the 2022 CDKL5 Forum Hosted by the Loulou Foundation
Nov 10, 2022 08:00AM Vyant Bio to Participate at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12-16
Nov 10, 2022 08:00AM Vyant Bio to Participate at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12-16
Nov 7, 2022 09:00AM Vyant Bio Teams Up with the International Rett Syndrome Foundation to Host Local Viewing Party in Honor of the 3rd Annual ‘Raise a Glass for Rett Gala’
Nov 7, 2022 09:00AM Vyant Bio Teams Up with the International Rett Syndrome Foundation to Host Local Viewing Party in Honor of the 3rd Annual ‘Raise a Glass for Rett Gala’
Nov 3, 2022 09:10AM Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary
Nov 3, 2022 09:10AM Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary
Nov 1, 2022 08:01AM Vyant Bio (VYNT) Announces 1-for-5 Reverse Stock Split
Nov 1, 2022 08:00AM Vyant Bio Announces One-for-Five Reverse Stock Split
Nov 1, 2022 08:00AM Vyant Bio Announces One-for-Five Reverse Stock Split
Oct 27, 2022 05:10PM Vyant Bio Announces Participation at the 2022 CDKL5 Forum Hosted by the Loulou Foundation on November 7-8, 2022
Oct 27, 2022 05:10PM Vyant Bio Announces Participation at the 2022 CDKL5 Forum Hosted by the Loulou Foundation on November 7-8, 2022
Oct 24, 2022 04:15PM Vyant Bio to Present at the LD Micro Main Event XV on Wednesday, October 26, 2022
Oct 24, 2022 04:15PM Vyant Bio to Present at the LD Micro Main Event XV on Wednesday, October 26, 2022
Sep 1, 2022 08:00AM Vyant Bio to Deliver a Live Presentation at the Skyline Signature Series™ on Thursday, September 8, 2022
Sep 1, 2022 08:00AM Vyant Bio to Deliver a Live Presentation at the Skyline Signature Series™ on Thursday, September 8, 2022
Aug 31, 2022 08:00AM Vyant Bio to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Aug 31, 2022 08:00AM Vyant Bio to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Aug 22, 2022 04:10PM Vyant Bio Reports Second Quarter and First Half 2022 Results and Provides Strategic and Business Highlights
Aug 22, 2022 04:10PM Vyant Bio Reports Second Quarter and First Half 2022 Results and Provides Strategic and Business Highlights
Aug 19, 2022 09:29AM Vyant Bio Announces Rescheduled Investor Conference Call and Webcast for the Second Quarter and First Half of 2022
Aug 19, 2022 09:29AM Vyant Bio Announces Rescheduled Investor Conference Call and Webcast for the Second Quarter and First Half of 2022
Aug 15, 2022 08:05AM Vyant Bio Postpones Second Quarter Investor Conference Call and Webcast
Aug 15, 2022 08:05AM Vyant Bio Postpones Second Quarter Investor Conference Call and Webcast
Aug 11, 2022 08:00AM Vyant Bio Announces Investor Conference Call and Webcast for the Second Quarter and First Half of 2022
Aug 11, 2022 08:00AM Vyant Bio Announces Investor Conference Call and Webcast for the Second Quarter and First Half of 2022
Jun 1, 2022 06:05PM Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
Jun 1, 2022 06:05PM Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
May 5, 2022 04:30PM Vyant Bio Announces Participation in BioNJ’s 12th Annual BioPartnering Conference
May 5, 2022 04:30PM Vyant Bio Announces Participation in BioNJ’s 12th Annual BioPartnering Conference
Mar 30, 2022 07:50AM Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights
Mar 30, 2022 07:50AM Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights
Mar 29, 2022 05:01PM Vyant Bio (VYNT) and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease
Mar 29, 2022 05:00PM Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease
Mar 29, 2022 05:00PM Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease
Mar 28, 2022 04:30PM Vyant Bio Announces Investor Conference Call and Webcast for the Year-End 2021
Mar 28, 2022 04:30PM Vyant Bio Announces Investor Conference Call and Webcast for the Year-End 2021
Mar 1, 2022 08:34AM Vyant Bio (VYNT) Issues Letter to Shareholders
Mar 1, 2022 08:30AM Vyant Bio Issues Letter to Shareholders
Jan 10, 2022 08:00AM Vyant Bio to Present at the H.C. Wainwright Bioconnect Conference
Jan 10, 2022 08:00AM Vyant Bio to Present at the H.C. Wainwright Bioconnect Conference
Nov 11, 2021 04:00PM Vyant Bio Reports Third Quarter 2021 Results and Provides Strategic Business Updates
Nov 11, 2021 04:00PM Vyant Bio Reports Third Quarter 2021 Results and Provides Strategic Business Updates
Aug 16, 2021 04:01PM Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates
Aug 16, 2021 04:01PM Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates
View More Recent Stories View Older Stories